Sailing: Swiss team Decouvertes-GeoMod wins the J/70 world championship in Monaco

MONACO, Oct. 24, 2022 (GLOBE NEWSWIRE) — The J/70 world championship, organized by the Yacht Club de Monaco, ends with the victory of the Swiss team Decouvertes-GeoMod. The crew, formed by Kilian Wagen, Gregeoire Siegwart, Luke Patience, David Hughes, Celia Wilson, finished on the top step of the podium followed by the Monegasque team Leonteq with Pierrik Devic, Francois Brenac, Stephane Christidis, Axelle Foucaud, Martin Lemarchand. Bronze medal to the Americans Peter Duncan, Willam Van Waay, Morgan Trubovich and Victor Diaz de Leon with their boat Relative Obscurity.  “We are world champions and with my team we are very happy with the result – says Luke Patience -. We came to Monaco to win and we worked very hard. We didn’t expect it. It was great and I sailed with some old friends. There was a moment when I thought that our points were good and that if we could finish the race in a certain position then we could become world champions. It is a strange feeling: you don’t want to say it in your head because otherwise you risk losing focus instead you have to keep your attention up. I didn’t tell what I thought to the other teammates, I kept it to myself. The conditions were difficult because the wind kept changing but in English we say ‘fortune favors the brave’ and that’s what happened today.”  The world championship was the first one to be organised in Monaco since 1976: “It was amazing for the Yacht Club. As the vice president – underlines Pierre Casiraghi – it’s a fantastic event. We’ve been working for years and I want to thank all the team of the Yacht Club that did an amazing job but also the sailors that came here and fought to get the best result. We’re very proud  we have a vice world champion from the club and Monaco so to us it’s a great honor. I want to congratulate the winners, the Swiss team, they did an amazing job, very consistent all day. We’re very happy and hope we can organize more events of this magnitude.”  Some 400 sailors, 90 teams, 23 nations took part to the competition organised by the Yacht Club de Monaco in partnership with the Monegasque Sailing Federation, FxPro, Sebago and technical sports clothing brand Slam which supplied garments for all crew members on the podium.

For more information:

LaPresse SpA Communication and Press Office Director
Barbara Sanicola –

A video accompanying this announcement is available at

GlobeNewswire Distribution ID 8681027

Expereo appoints new Chief Human Resources Officer and Executive Board Member

AMSTERDAM, Oct. 24, 2022 (GLOBE NEWSWIRE) — Expereo, global provider of managed Internet and hybrid networks, SD-WAN and Cloud connectivity solutions, welcomes Victoria Marshall-Rice as its new Chief Human Resources Officer (CHRO) and Executive Board Member. This appointment expands upon Expereo’s ongoing commitment to sourcing and retaining the best talent to help organisations improve productivity and enhance performance.

“We are thrilled to have someone of Victoria’s standing join Expereo,” says Irwin Fouwels, Chief Executive Officer at Expereo. “With her expertise and experience, Victoria will be instrumental in continuing to build and develop Expereo’s growing team to deliver strategic capabilities and unparalleled service that delights our customers, whilst building a culture that attracts, retains and develops the best team worldwide.”

Marshall-Rice joins Expereo from Vodafone Business, where she was the Head of Human Resources and worked closely with the CEO and senior management team to lead the development and execution of a business and culture transformation strategy for Enterprise Sales.

With a strong background in various HR leadership roles, she is recognised as a culture change leader with a proven record of developing strong talent and leadership teams to deliver organisational excellence. Marshall-Rice will be critical in positioning Expereo for future growth.

“My driving force and passion is around creating ‘admired places to work’. I believe HR should be focused on supporting and empowering customer-obsessed organisations, fostering a companywide ‘growth’ mindset, and partnering with every area of the business to meet and exceed goals,” says Marshall-Rice.

Marshall-Rice embraces working closely with executive teams to build the most effective work communities, and is committed to ensuring employees are enabled to perform at their best.

About Expereo
Expereo is a leading global provider of managed network solutions including, Global Internet, SD-WAN/SASE, and Enhanced Internet. With an extensive global reach, Expereo is the trusted partner of 30% of Fortune 500 companies. It powers enterprise and government sites in more than 190 countries, helping customers improve productivity and empowering their networks and cloud services with the agility, flexibility and value of the Internet, with optimal network performance.

Expereo was acquired in Feb 2021, by Vitruvian Partners. The international growth capital and buyout firm acquired a majority shareholding from leading European private equity firm, Apax Partners sas.

For more information visit:


Emese Csikai

GlobeNewswire Distribution ID 8681007

Luiss Rector Andrea Prencipe Received the Journal of Business Venturing’s Best Paper Award

Andrea Prencipe

Luiss Rector Andrea Prencipe received the Journal of Business Venturing’s Best Paper Award for the paper “The Language of Investments:How Language-Structure Influences Crowdfunding Investments.”

ROME, Oct. 24, 2022 (GLOBE NEWSWIRE) — Luiss Rector Andrea Prencipe received the Journal of Business Venturing’s Best Paper Award for the paper “The Language of Investments: How Language-Structure Influences Crowdfunding Investments.” The study was conducted with Professors Francesca Di Pietro, University Milano Bicocca, Francesca Masciarelli, University G. d’Annunzio Pescara, and Vangelis Souitaris, Cass Business School. It explores how language can predict individuals’ investment choices and their propensity for entrepreneurship. The study relies on the assumption that language predicts people’s investment behaviour and entrepreneurial propensity. Languages are divided into those that rarely distinguish present and future time (such as German, Dutch, Swedish, and Chinese, i.e., weak-future languages, and those that have a marked distinction between present and future time such as French, Italian and English, i.e., strong-future languages. Speakers of weak-future languages appear to perceive future events as closer than do speakers of strong-future languages. Speakers of weak-future languages are likely attracted to the idea of personally investing in entrepreneurial ventures, including crowdfunding investments. By linking language, culture, cognitive frames and economic behaviours, the study adds an important and interdisciplinary explanation for cross-country variation in early-stage crowdfunding investment, and our findings have important practical implications for entrepreneurs, crowdfunding investors, and policymakers.

This important award confirms that in Luiss the education model combines academic rigour but, at the same time, practical relevance. «Our faculty comprises academic professors and practitioners from the real world – meaning executives, diplomats, representatives from public administration», said Luiss University Dean, Andrea Prencipe. Rome’s Luiss University is revered for both its physical beauty and educational excellence, blending its rich history with the digital age of the present to prepare students that shape the future. Throughout its four departments of Economics and Finance, Business and Management, Law and Political Science, the private university offers an innovative educational approach which is gaining increasing international recognition.

«In Luiss students will have the opportunity to grow their mindset. They will have the opportunity to acquire tools that will enable them to face the complexity and the discontinuities of the challenges that they will face once they will enter the job market. Those challenges, as we know, are increasingly complex, often more discontinuous. So a change in the mindset is fundamental and our programs do that», said Prencipe.

For more information:

LaPresse SpA Communication and Press Office Director
Barbara Sanicola –

A photo accompanying this announcement is available at

The photo is also available at Newscom,, and via AP PhotoExpress.

GlobeNewswire Distribution ID 8680988

Taconic Biosciences Launches First and Only Super Immunodeficient Mouse Models Lacking Residual Murine Fc Gamma Receptors, for Improved Antibody Therapy Assessment

FcResolv™ NOG Models Provide Greater Clarity and More Translatable Data

RENSSELAER, N.Y., Oct. 24, 2022 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, has launched the FcResolv™ NOG portfolio, the first and only super immunodeficient mouse models lacking residual murine Fc gamma receptors (FcγRs) known to confound results in antibody-based therapy studies.

Murine FcγRs can cause false positives or false negatives, leading to incorrect conclusions and derail drug discovery. FcResolv NOG models knock out these receptors for greater clarity in antibody-based drug studies, affording investigators greater confidence and more translatable data with fewer studies and fewer animals. With applicability in oncology, immuno-oncology, and autoimmune disease, FcResolv NOG models are suitable for engrafting a wide range of human cells and tissues, including simultaneous human tumor engraftment and immune system humanization.

“Antibody-based therapies represent one of the fastest-growing classes of drugs, creating a pressing need for better preclinical tools to assess therapeutics such as monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies,” said Dr. Michael Seiler, vice president of commercial products at Taconic. “Taconic’s FcResolv NOG portfolio enables researchers to evaluate drug candidates like these on their own merits, free of interference from residual murine Fc gamma receptor activity.”

FcResolv NOG models eliminate the false negatives that occur when an antibody-based therapeutic’s Fc domain interacts with murine FcγRs as well as the false positives that result when FcγRs trigger residual murine immune activity. They also eliminate costly deconvolution steps otherwise needed to distinguish true drug efficacy from off-target effects mediated through the mouse immune system. With more reliable answers, researchers can target their drug discovery investments more strategically and effectively.

The FcResolv NOG model portfolio is based on the super immunodeficient CIEA NOG mouse®. The portfolio currently includes two models:

  • FcResolv NOG, for tumor xenografts using cell lines or patient-derived tumors, engraftment of other normal or pathological human cells and tissues, and immune system humanization studies
  • FcResolv hIL-15 NOG, which supports engraftment of human NK cells and is suitable for efficacy studies on antibody-based therapeutics with an antibody-dependent cellular cytotoxicity (ADCC) mechanism of action

To learn more about the FcResolv NOG portfolio, visit Or call 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe, or email

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom-generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, microbiome, immuno-oncology mouse models, and integrated model design and breeding services, Taconic operates service laboratories and breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:

Louise Baskin, Senior Director New Product Pipeline


GlobeNewswire Distribution ID 8670208

Innova Medical Group Announces Successful FDA Field Inspection Results and Formal Warning Letter Close-Out

PASADENA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) — Innova Medical Group, Inc. (“Innova”), a global leader in antigen testing, announced that it has received from the United States Food and Drug Administration (“FDA”) a letter formally closing out the Warning Letter originally sent to the company on June 10, 2021.

This close-out letter was received following an on-site FDA field inspection where FDA reviewed, among other things, Innova’s remediation of the concerns raised in the Warning Letter.  The evidence presented to FDA during the inspection demonstrated that Innova had successfully addressed the Warning Letter. The inspection was successfully completed with no observations and no Form 483.

Dr. Charles Huang, Founder and CEO of Innova Medical Group Inc, said: “Innova Medical Group is committed to complying with all legal and regulatory requirements anywhere it operates or conducts business.  Now, with FDA’s Warning Letter behind us, Innova will focus its efforts in executing its mission of bringing innovative medical products to as many people as possible in the most efficient and effective manner.”

About Innova Medical Group Inc.

Innova Medical Group is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions. Its strategic and iterative approach is to create, build, deploy and distribute a wide array of innovative, accessible tests customized to meet and empower the user at their respective point of need.

Contact Information:
Sunny Sun
Head of Group Communications

This content was issued through the press release distribution service at

GlobeNewswire Distribution ID 8680587